Back to portfolio


Zilia's revolutionary technology platform addresses an unmet clinical need for the early assessment of biomarkers related to eye disease - all to preserve the vision of millions of people.

Combining imaging, spectrometry and artificial intelligence, Zilia's unique technology is amassing a whole new kind of clinical data, paving the way for a multitude of future applications ranging from neurology, cardiology, oncology and intensive care.


Sector of activity

  • Life sciences